Mydriatic Agent
Mydriatic Agent is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
No phase data available
Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Status
Recent Activity
Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model
Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images
Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device
Assessment of EyeArt Performance With Retinal Cameras
Assessment of EyeArt Performance With Retinal Imaging Devices
Clinical Trials (7)
Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model
Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images
Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device
Assessment of EyeArt Performance With Retinal Cameras
Assessment of EyeArt Performance With Retinal Imaging Devices
Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7